Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
55,499,247
-
Share change
-
-7,516,716
-
Total reported value
-
$157,041,490
-
Put/Call ratio
-
132%
-
Price per share
-
$2.83
-
Number of holders
-
103
-
Value change
-
-$57,851,659
-
Number of buys
-
57
-
Number of sells
-
50
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q1 2016
As of 31 Mar 2016,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,499,247 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VHCP Management II, LLC, D. E. Shaw & Co., Inc., VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, RTW INVESTMENTS, LLC, BlackRock Institutional Trust Company, N.A., FRANKLIN RESOURCES INC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
103
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.